Key Metrics
MARKET CAP
$27.59B
P/E RATIO
21.4
BETA
0.16
Less volatile
DIV YIELD
N/A
52W HIGH
$202.41
52W LOW
$110.04
VOLATILITY
41.2%
30d annualized
Price Performance
30-DAY PRICE CHART
$174.12 → $188.02+7.98%
30 days agoToday
1-YEAR PERFORMANCE
$140.50 → $188.02+33.8%
BIIB | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Biogen Inc. is currently trading at $188.02, which is 7.1% below its 52-week high. With a beta of 0.16, the stock shows lower sensitivity to market movements.
RSI (14)NEUTRAL
30-DAY TRENDBULLISH
VOLUME1.0M(Below avg)
Frequently Asked Questions
Is BIIB a good buy right now?
Biogen Inc. trades at 21.4x earnings. This is near market average. Current risk level is High based on 41.2% volatility.
Does BIIB pay dividends?
Biogen Inc. does not currently pay a regular dividend. The company may be reinvesting profits for growth.
How volatile is BIIB?
With 30-day annualized volatility of 41.2% and beta of 0.16,BIIB is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track BIIB Live
Add Biogen Inc. to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:51 PM